Table 4. Linear regression results for disease phenotype, IBD genotype and additional clinical covariates (see Table 1) and the relative abundance of the C. coccoides-E. rectales bacterial subgroup and F. prausnitzii.
C. coccoides-E-rectales bacterial subgroup | Log fold change | p-value | FDR |
---|---|---|---|
Main effects | |||
ileal CD | 0.129 | 0.772 | 0.772 |
Colitis | 1.456 | 0.002 | 0.004 |
Immunomodulators | -0.762 | 0.095 | 0.143 |
C. difficile fecal toxin | -1.08 | 0.290 | 0.347 |
First order interactions | |||
Immunomodulators* C. difficile fecal toxin | 4.71 | 0.001 | 0.004 |
Faecalibacterium prausnitzii | Log fold change | p-value | FDR |
Main effects | |||
ileal CD | -1.691 | 0.001 | 0.001 |
Colitis | -0.930 | 0.074 | 0.074 |